Research map: The role of necroptosis as a possible therapeutic target in multiple myeloma: the emerging roles of necroptosis
Back to the article
Papers in this map
Necroptosis, pyroptosis and apoptosis: an intricate game of cell death
· Damien Bertheloot · 2021 · 2225 citations · Cited by this paper
In search of dependencies in myeloma, consider IRF2 too
· Elisa Taìana · 2026 · Cites this paper
Case Report: A converging pathology: Chediak–Higashi syndrome and IEI-associated lymphoproliferative disease
· 2026 · Related
Necroptosis and its role in inflammation
· Manolis Pasparakis · 2015 · 2182 citations · Cited by this paper
Soluble immune checkpoint landscape in sickle cell disease links systemic inflammation, autoimmunity, and pain
· 2025 · Related
Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
· Agnieszka Kaczmarek · 2013 · 1432 citations · Cited by this paper
Advances in Chimeric Antigen Receptor T-cell therapy for hematologic malignancies and autoimmune conditions: a review of the 2024 American Society of Hematology Annual Meeting
· 2025 · Related
The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis
· Jixi Li · 2012 · 1247 citations · Cited by this paper
Portuguese real-world experience with ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma
· 2025 · Related
Multiple myeloma
· Niels W.C.J. van de Donk · 2021 · 895 citations · Cited by this paper
Real-world data of azacitidine for relapsed/refractory nodal T-follicular helper cell lymphoma in 11 patients
· 2025 · Related
The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs
· Tencho Tenev · 2011 · 829 citations · Cited by this paper
Case Report: two cases of idiopathic plasmacytic lymphadenopathy subtype of idiopathic multicentric Castleman disease with xanthelasma palpebrum from a Canadian center
· 2026 · Related
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
· Lena Seifert · 2016 · 631 citations · Cited by this paper
Complications and treatment patterns in patients with non-transfusion-dependent α- and β-thalassemia compared with matched controls: a retrospective observational study using administrative claims data in the United States
· 2026 · Related
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
· Abdel Kareem Azab · 2009 · 430 citations · Cited by this paper
Associations with the quality of life of adult family members or partners (informal carers) of people with leukaemia: results from a cross-sectional online global survey
· 2026 · Related
Cancer therapy in the necroptosis era
· Zhenyi Su · 2016 · 337 citations · Cited by this paper
Understanding therapy-related AML: genetic insights and emerging strategies for high-risk patients
· 2025 · Related
The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis
· Michio Onizawa · 2015 · 288 citations · Cited by this paper
The “added value” of enrolling hematological patients in clinical trials: a single-center experience
· 2025 · Related
Interleukin-6 Inhibits Fas-Induced Apoptosis and Stress-Activated Protein Kinase Activation in Multiple Myeloma Cells
· Dharminder Chauhan · 1997 · 271 citations · Cited by this paper
MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death
· Yves Dondelinger · 2017 · 210 citations · Cited by this paper
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells
· Ulrike Höckendorf · 2016 · 207 citations · Cited by this paper
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
· Heng Yang · 2016 · 191 citations · Cited by this paper
Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target
· Jing Chen · 2019 · 179 citations · Cited by this paper
Anti-α4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis
· Yoshihisa Mori · 2004 · 177 citations · Cited by this paper
The role of necroptosis in cancer: A double-edged sword?
· Xia Qin · 2019 · 129 citations · Cited by this paper
PELI1 Selectively Targets Kinase-Active RIP3 for Ubiquitylation-Dependent Proteasomal Degradation
· Seung-Won Choi · 2018 · 123 citations · Cited by this paper
Current translational potential and underlying molecular mechanisms of necroptosis
· Tamás F. Molnar · 2019 · 108 citations · Cited by this paper
Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
· David C. Johnson · 2011 · 102 citations · Cited by this paper
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells
· Naoko A. Wada · 2014 · 75 citations · Cited by this paper
Regulation of RIPK3- and RHIM-dependent Necroptosis by the Proteasome
· Kenta Moriwaki · 2016 · 75 citations · Cited by this paper
Immunogenic cell death in cancer immunotherapy
· Minji Choi · 2023 · 74 citations · Cited by this paper
Immunogenic Cell Death in Hematological Malignancy Therapy
· Zhaoyun Liu · 2023 · 62 citations · Cited by this paper
Differential effect of pharmacological autonomic blockade on some electrophysiological properties of the human ventricle and atrium.
· Wataru Shimizu · 1994 · 52 citations · Cited by this paper
Omega-3 Fatty Acids DHA and EPA Reduce Bortezomib Resistance in Multiple Myeloma Cells by Promoting Glutathione Degradation
· Jing Chen · 2021 · 51 citations · Cited by this paper
HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells
· Rajesh R. Nair · 2009 · 46 citations · Cited by this paper
The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma
· Kanagaraju Ponnusamy · 2021 · 45 citations · Cited by this paper
Source: OpenAlex (CC0)